​

BrainsWay (BWAY) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

BWAY Stock Forecast

BrainsWay (BWAY) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $16.00, with a high of $18.00 and a low of $14.00. This represents a 3.23% increase from the last price of $15.50.

$5 $8 $11 $14 $17 $20 High: $18 Avg: $16 Low: $14 Last Closed Price: $15.5

BWAY Stock Rating

BrainsWay stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

BWAY Price Target Upside V Benchmarks

TypeNameUpside
StockBrainsWay3.23%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks16.81%

Price Target Trends

1M3M12M
# Anlaysts236
Avg Price Target$16.00$16.33$15.17
Last Closing Price$15.50$15.50$15.50
Upside/Downside3.23%5.35%-2.13%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Aug, 26-3---3
Jul, 26-2---2
Jun, 26-3---3
May, 26-3---3
Apr, 26-3---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 20, 2026BTIG$18.00$15.7314.43%16.13%
Jul 17, 2026Raghuram SelvarajuH.C. Wainwright$14.00$14.84-5.66%-9.68%
May 26, 2026Raghuram SelvarajuH.C. Wainwright$17.00$15.1012.58%9.68%
Jan 26, 2026H.C. Wainwright$30.00$23.0430.21%93.55%
Jan 22, 2026Northland Securities$30.00$24.6121.90%93.55%
Dec 08, 2025Raghuram SelvarajuH.C. Wainwright$24.00$17.2738.97%54.84%
Aug 07, 2024Raghuram SelvarajuH.C. Wainwright$16.00$6.89132.22%3.23%
May 09, 2024Steven LichtmanOppenheimer$11.00$5.7092.98%-29.03%
May 09, 2024Raghuram SelvarajuH.C. Wainwright$15.00$5.70163.16%-3.23%
Nov 17, 2022Northland Securities$5.00$1.98152.53%-67.74%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 24, 2026New StreetBuyBuyhold
Jul 20, 2026BTIGBuyinitialise
Jul 17, 2026H.C. WainwrightBuyBuyhold
Jun 15, 2026H.C. WainwrightBuyBuyhold
May 26, 2026H.C. WainwrightBuyBuyhold
Mar 13, 2026H.C. WainwrightBuyBuyhold
Jan 26, 2026H.C. WainwrightBuyBuyhold
Dec 08, 2025H.C. WainwrightBuyBuyhold
Aug 14, 2025H.C. WainwrightBuyBuyhold
Oct 21, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.41$-0.87$-0.26---
Avg Forecast$-0.26$-0.41$-0.14$0.06$0.12$0.21
High Forecast$-0.25$-0.40$-0.14$0.11$0.23$0.22
Low Forecast$-0.26$-0.42$-0.15$0.05$0.05$0.21
Surprise %57.69%112.20%85.71%---

Revenue Forecast

$25M $32M $39M $46M $53M $60M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$29.66M$27.18M$31.79M---
Avg Forecast$29.52M$27.42M$31.33M$40.45M$47.13M$57.10M
High Forecast$30.07M$28.04M$31.56M$40.54M$47.75M$57.11M
Low Forecast$28.92M$27.09M$31.16M$40.36M$46.74M$57.09M
Surprise %0.47%-0.90%1.46%---

Net Income Forecast

$-15M $-11M $-7M $-3M $1M $5M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-6.46M$-13.35M$-4.20M---
Avg Forecast$-4.28M$-6.80M$-2.37M$1.50M$2.32M$3.51M
High Forecast$-4.17M$-6.69M$-2.29M$1.81M$3.81M$3.62M
Low Forecast$-4.39M$-6.99M$-2.45M$777.09K$834.07K$3.41M
Surprise %50.89%96.40%77.12%---

BWAY Forecast FAQ

Is BrainsWay stock a buy?

BrainsWay stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BrainsWay is a favorable investment for most analysts.

What is BrainsWay's price target?

BrainsWay's price target, set by 6 Wall Street analysts, averages $16 over the next 12 months. The price target range spans from $14 at the low end to $18 at the high end, suggesting a potential 3.23% change from the previous closing price of $15.5.

How does BrainsWay stock forecast compare to its benchmarks?

BrainsWay's stock forecast shows a 3.23% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (16.81%).

What is the breakdown of analyst ratings for BrainsWay over the past three months?

  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is BrainsWay’s EPS forecast?

BrainsWay's average annual EPS forecast for its fiscal year ending in December 2024 is $0.06, marking a -123.08% decrease from the reported $-0.26 in 2023. Estimates for the following years are $0.12 in 2025, and $0.21 in 2026.

What is BrainsWay’s revenue forecast?

BrainsWay's average annual revenue forecast for its fiscal year ending in December 2024 is $40.45M, reflecting a 27.26% increase from the reported $31.78M in 2023. The forecast for 2025 is $47.12M, and $57.1M for 2026.

What is BrainsWay’s net income forecast?

BrainsWay's net income forecast for the fiscal year ending in December 2024 stands at $1.5M, representing a -135.74% decrease from the reported $-4.197M in 2023. Projections indicate $2.32M in 2025, and $3.51M in 2026.